Drug Repurposing for Alzheimer's Disease Based on Protein-Protein Interaction Network

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2021 Oct 25

PMID 34692825

Citations 8

Authors

Negar Sadat Soleimani Zakeri

Saeid Pashazadeh

Habib MotieGhader

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease (AD) is known as a critical neurodegenerative disorder. It worsens as symptoms concerning dementia grow severe over the years. Due to the globalization of Alzheimer's disease, its prevention and treatment are vital. This study proposes a method to extract substantial gene complexes and then introduces potential drugs in Alzheimer's disease. To this end, a protein-protein interaction (PPI) network was utilized to extract five meaningful gene complexes functionally interconnected. An enrichment analysis to introduce the most important biological processes and pathways was accomplished on the obtained genes. The next step is extracting the drugs related to AD and introducing some new drugs which may be helpful for this disease. Finally, a complete network including all the genes associated with each gene complex group and genes' target drug was illustrated. For validating the proposed potential drugs, Connectivity Map (CMAP) analysis was accomplished to determine target genes that are up- or downregulated by proposed drugs. Medical studies and publications were analyzed thoroughly to introduce AD-related drugs. This analysis proves the accuracy of the proposed method in this study. Then, new drugs were introduced that can be experimentally examined as future work. Raloxifene and gentian violet are two new drugs, which have not been introduced as AD-related drugs in previous scientific and medical studies, recommended by the method of this study. Besides the primary goal, five bipartite networks representing the genes of each group and their target miRNAs were constructed to introduce target miRNAs.

Citing Articles

Proteomic association with age-dependent sex differences in Wisconsin Card Sorting Test performance in healthy Thai subjects.

Chen C, Khanthiyong B, Thaweetee-Sukjai B, Charoenlappanit S, Roytrakul S, Thanoi S Sci Rep. 2023; 13(1):20238.

PMID: 37981639 PMC: 10658079. DOI: 10.1038/s41598-023-46750-4.

Application of Protein-Protein Interaction Network Analysis in Order to Identify Cervical Cancer miRNA and mRNA Biomarkers.

Tabrizi-Nezhadi P, MotieGhader H, Maleki M, Sahin S, Nematzadeh S, Torkamanian-Afshar M ScientificWorldJournal. 2023; 2023:6626279.

PMID: 37746664 PMC: 10513823. DOI: 10.1155/2023/6626279.

Drug repurposing for Alzheimer's disease from 2012-2022-a 10-year literature review.

Grabowska M, Huang A, Wen Z, Li B, Wei W Front Pharmacol. 2023; 14:1257700.

PMID: 37745051 PMC: 10512468. DOI: 10.3389/fphar.2023.1257700.

Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood.

Bourdakou M, Fernandez-Gines R, Cuadrado A, Spyrou G Redox Biol. 2023; 67:102881.

PMID: 37696195 PMC: 10500459. DOI: 10.1016/j.redox.2023.102881.

Overview of methods for characterization and visualization of a protein-protein interaction network in a multi-omics integration context.

Robin V, Bodein A, Scott-Boyer M, Leclercq M, Perin O, Droit A Front Mol Biosci. 2022; 9:962799.

PMID: 36158572 PMC: 9494275. DOI: 10.3389/fmolb.2022.962799.

References

Melchor J, Pawlak R, Strickland S . The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration. J Neurosci. 2003; 23(26):8867-71. PMC: 6740393. View

Luine V . Estradiol and cognitive function: past, present and future. Horm Behav. 2014; 66(4):602-18. PMC: 4318702. DOI: 10.1016/j.yhbeh.2014.08.011. View

Hanyu H, Hirao K, Shimizu S, Kanetaka H, Sakurai H, Iwamoto T . Phenylephrine and pilocarpine eye drop test for dementia with Lewy bodies and Alzheimer's disease. Neurosci Lett. 2007; 414(2):174-7. DOI: 10.1016/j.neulet.2006.12.015. View

Mair G, von Kummer R, Morris Z, von Heijne A, Bradey N, Cala L . Effect of IV alteplase on the ischemic brain lesion at 24-48 hours after ischemic stroke. Neurology. 2018; 91(22):e2067-e2077. PMC: 6282236. DOI: 10.1212/WNL.0000000000006575. View

Szklarczyk D, Gable A, Lyon D, Junge A, Wyder S, Huerta-Cepas J . STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2018; 47(D1):D607-D613. PMC: 6323986. DOI: 10.1093/nar/gky1131. View

Bartels A, Willemsen A, Kortekaas R, de Jong B, de Vries R, de Klerk O . Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA. J Neural Transm (Vienna). 2008; 115(7):1001-9. PMC: 2468317. DOI: 10.1007/s00702-008-0030-y. View

Zsido R, Heinrich M, Slavich G, Beyer F, Masouleh S, Kratzsch J . Association of Estradiol and Visceral Fat With Structural Brain Networks and Memory Performance in Adults. JAMA Netw Open. 2019; 2(6):e196126. PMC: 6593958. DOI: 10.1001/jamanetworkopen.2019.6126. View

Newhouse P, Albert K, Astur R, Johnson J, Naylor M, Dumas J . Tamoxifen improves cholinergically modulated cognitive performance in postmenopausal women. Neuropsychopharmacology. 2013; 38(13):2632-43. PMC: 3828534. DOI: 10.1038/npp.2013.172. View

Im W, Ban J, Chung J, Lee S, Chu K, Kim M . Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington's disease R6/2 model. Sci Rep. 2015; 5:16887. PMC: 4653614. DOI: 10.1038/srep16887. View

10.

Lamb J, Crawford E, Peck D, Modell J, Blat I, Wrobel M . The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006; 313(5795):1929-35. DOI: 10.1126/science.1132939. View

11.

Terry Jr A, Gearhart D, Warner S, Zhang G, Bartlett M, Middlemore M . Oral haloperidol or risperidone treatment in rats: temporal effects on nerve growth factor receptors, cholinergic neurons, and memory performance. Neuroscience. 2007; 146(3):1316-32. PMC: 1978102. DOI: 10.1016/j.neuroscience.2007.03.003. View

12.

Chen K, Reese E, Kim H, Rapoport S, Rao J . Disturbed neurotransmitter transporter expression in Alzheimer's disease brain. J Alzheimers Dis. 2011; 26(4):755-766. PMC: 3188700. DOI: 10.3233/JAD-2011-110002. View

13.

Simpkins J, Perez E, Wang X, Yang S, Wen Y, Singh M . The potential for estrogens in preventing Alzheimer's disease and vascular dementia. Ther Adv Neurol Disord. 2009; 2(1):31-49. PMC: 2771945. DOI: 10.1177/1756285608100427. View

14.

Wang J, Zhong J, Chen G, Li M, Wu F, Pan Y . ClusterViz: A Cytoscape APP for Cluster Analysis of Biological Network. IEEE/ACM Trans Comput Biol Bioinform. 2015; 12(4):815-22. DOI: 10.1109/TCBB.2014.2361348. View

15.

Niculescu A, Le-Niculescu H, Roseberry K, Wang S, Hart J, Kaur A . Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs. Mol Psychiatry. 2019; 25(8):1651-1672. PMC: 7387316. DOI: 10.1038/s41380-019-0602-2. View

16.

Rezaei-Tavirani M, Zamanian-Azodi M, Rajabi S, Masoudi-Nejad A, Rostami-Nejad M, Rahmatirad S . Protein Clustering and Interactome Analysis in Parkinson and Alzheimer's Diseases. Arch Iran Med. 2016; 19(2):101-9. DOI: 0161902/AIM.007. View

17.

Liao K, Lin C, Lai S . Nationwide Case-Control Study Examining the Association between Tamoxifen Use and Alzheimer's Disease in Aged Women with Breast Cancer in Taiwan. Front Pharmacol. 2017; 8:612. PMC: 5591818. DOI: 10.3389/fphar.2017.00612. View

18.

Dysken M, Johnson S, Holden L, Vatassery G, Nygren J, Jelinski M . Haloperidol Concentrations in Patients With Alzheimer's Dementia. Am J Geriatr Psychiatry. 2017; 2(2):124-133. DOI: 10.1097/00019442-199405000-00006. View

19.

Chen E, Tan C, Kou Y, Duan Q, Wang Z, Meirelles G . Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013; 14:128. PMC: 3637064. DOI: 10.1186/1471-2105-14-128. View

20.

Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View